Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types
Open Access
- 1 November 1994
- Vol. 74 (9) , 2555-2561
- https://doi.org/10.1002/1097-0142(19941101)74:9<2555::aid-cncr2820740925>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Is Extrapituitary Action of Gonadotrophin-Releasing Hormone Biologically Significant?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Hormonal manipulation of prostatic cancer.BMJ, 1991
- A Controlled Trial of Castration With and Without Nilutamide in Metastatic Prostatic CarcinomaCancer, 1990
- Zoladex and Flutamide Versus Orchiectomy in the Treatment of Advanced Prostatic CancerCancer, 1990
- Zoladex: Endocrine and therapeutic effects in post-menopausal breast cancerBritish Journal of Cancer, 1989
- Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancerBiomedicine & Pharmacotherapy, 1989
- A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostateCancer, 1988
- Treatment of Breast Cancer with Gonadotropin-Releasing HormoneEndocrine Reviews, 1986
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent CancersExperimental Biology and Medicine, 1984